Inducing a calorie deficit that often results in rapid weight loss
We also used the actual semaglutide group treatment effects (rather than placebo-adjusted) which are felt to better represent the real-world effects we are projecting the STEP 1 trial results to
Ozempic is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis, due to the risk of worsening symptoms
Separately, orforglipron (Foundayo) - a daily oral GLP-1 receptor agonist pill from Eli Lilly - also received FDA approval in May 2026 for weight management
Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice
Glutathione infusions work at the cellular level, reducing inflammation and neutralizing free radicals that exacerbate pain conditions, such as: Nerve damage caused by chemotherapy, diabetes, or autoimmune disorders can lead to burning, shooting, or stabbing pain